• Mashup Score: 3
    Key trial updates from IMW 2021 - 3 year(s) ago

    VJHemOnc is excited to bring you the latest updates from 18th International Myeloma Workshop (IMW) 2021, which brought together leading experts to share the most recent and exciting new developments in the field of myeloma, covering areas including novel immunotherapies, CAR-T, MRD and more.

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      Catch up on highlights from the #IMW2021 meeting in our latest #VJToday article! 🔸 Isatuximab short-duration fixed volume plus VRD 🔸 MASTER trial 🔸 CARTITUDE-2 trial 🔸 Carfilzomib combinations 📰 Read here: https://t.co/QpzAhOyfNq @VJHemOnc #Myeloma #MMsm #MultipleMyeloma

  • Mashup Score: 6
    The future myeloma treatment landscape - 3 year(s) ago

    Jesús San Miguel, MD, PhD, University of Navarra Clinic, Pamplona, Spain, talks on the future of myeloma treatment, highlighting research…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      Jesús San Miguel (@unav) shares his thoughts on the future of #Myeloma treatment ⭐Discussing precursor B-cells, the microenvironment, circulating plasma cells & resistance⭐ https://t.co/HHoUwezidx @Myeloma_Society #IMW2021 #IMW21 #MMsm #HemOnc #BloodCancerAwarenessMonth #BCAM

  • Mashup Score: 5
    IMW 2021: treatment-free intervals in multiple myeloma - 3 year(s) ago

    Continuous therapy has been a key aspect of the standard of care approaches for the treatment of multiple myeloma for…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      #VJSounds | Can we give patients with #MultipleMyeloma treatment-free intervals? Hear the opinions of Philip McCarthy (@PLMcCarthyMD) and Luciano Costa (@End_myeloma) in our latest podcast! 👨‍⚕️👨‍⚕️ 🎧 Listen here: https://t.co/noSKmHMLIt @VJHemOnc #IMW2021 #MMsm #Myeloma

  • Mashup Score: 1
    MRD in myeloma: the FDA perspective - 3 year(s) ago

    Hermann Einsele, MD, FRCP, of the University of Würzburg, Würzburg, Germany, and Heinz Ludwig, MD, of the Wilhelminen Cancer Research…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      🩸MRD in #Myeloma Hermann Einsele (@Uni_WUE) & Heinz Ludwig discuss #MRD assessment for the treatment of myeloma, talking on the FDA perspective: https://t.co/aggyuVPsR1 @Myeloma_Society #IMW2021 #IMW21 #MultipleMyeloma #MMsm #HemOnc #mmMRD #CancelBloodCancer #BCAM

  • Mashup Score: 2
    IMW 2021: MRD in myeloma - 3 year(s) ago

    Measurable residual disease (MRD) is emerging as an important prognostic marker in the management of multiple myeloma. Promising clinical evidence…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      #VJSounds | Updates on MRD for #Myeloma Catch up on the latest data from #IMW2021 on MRD-guided adaptive therapy and MRD as a prognostic marker in #MultipleMyeloma in our latest podcast 📊🔬🧬 🎧 Listen here: https://t.co/AI6KnptKP6

  • Mashup Score: 2
    Updates on ide-cel and cilta-cel for myeloma - 3 year(s) ago

    Saad Usmani, MD, MBBS, MBA, of Levine Cancer Institute/Carolinas HealthCare System, Charlotte, NC, gives an overview of the latest updates…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      Latest updates on the use of #CART for #Myeloma @szusmani of @LevineCancer discusses ide-cel and cilta-cel 👉https://t.co/1NSV0ZIyKI👈 @VJHemOnc @Myeloma_Society #IMW2021 #IMW21 #MultipleMyeloma #MMsm #HemOnc #BloodCancerAwarenessMonth #CancelBloodCancer #BCAM

  • Mashup Score: 0
    My top 5 communications from the 18th IMW - 3 year(s) ago

    During the 18th International Myeloma Workshop, the Multiple Myeloma Hub spoke with Hermann Einsele, Julius-Maximilians-Universität Würzburg, Würzburg, DE. He discussed the top five communications from the 18th International Myeloma Workshop (IMW).

    Source: multiplemyelomahub.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MM_Hub
      MM_Hub

      📹 #IMW2021 | The @MM_Hub spoke with @H_Einsele, Julius-Maximilians-Universität Würzburg, Würzburg, DE. He discussed the top five communications from the 18th International #Myeloma Workshop (IMW). #mmsm #BloodCancerAwarenessMonth 🩸 https://t.co/iW9OHHgmwR

  • Mashup Score: 1
    Future maintenance therapy approaches for multiple myeloma - 3 year(s) ago

    Phil McCarthy, MD, of the Roswell Park Comprehensive Cancer Center, Buffalo, NY, discusses future approaches to maintenance therapy for multiple…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      🔮 Future maintenance therapy approaches for #Myeloma Hear from @PLMcCarthyMD of @RoswellPark ▶️ Watch: 👉https://t.co/2ryScXqqS2👈 @Myeloma_Society #IMW2021 #IMW21 #MultipleMyeloma #MMsm #HemOnc #BloodCancerAwarenessMonth #CancelBloodCancer #BCAM

Load More